- Home
- PBM
as 12-18-2024 3:37pm EST
Stocks
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
| Founded: | 1994 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -588.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.67 - $945.15 | Next Earning Date: | 02-02-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PSYENCE BIOMEDICAL LTD News
PBM Breaking Stock News: Dive into PBM Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial
TipRanks
7 days ago
Psyence Biomedical executes binding agreements with Optimi Health
GlobeNewswire
8 days ago
Psyence Biomed Executes Binding Agreements with Optimi Health Corp.
GlobeNewswire
12 days ago
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations
GlobeNewswire
15 days ago
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
Market Exclusive
24 days ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
GlobeNewswire
a month ago
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing
GlobeNewswire
a month ago
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation
Compare PBM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBM PSYENCE BIOMEDICAL LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.